• Issue

    Catheterization and Cardiovascular Interventions: Volume 88, Issue 4

    501-670, E103-E131
    October 2016
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Coronary Artery Disease

Original Studies

Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials

Islam Y. Elgendy MD,  Xuerong Wen PhD,  Ahmed Mahmoud MD,  Anthony A. Bavry MD, MPH, 
  • Pages: 501-505
  • First Published: 03 November 2015

Editorial Comment

The Third Rail of Interventional Cardiology: Revascularization of Non-Infarct-Related Arteries During Primary PCI

Robert D. Safian MD, 
  • Pages: 506-507
  • First Published: 19 October 2016
Key Points

  • Despite current guidelines, there is expanding evidence for the safety and efficacy of routine multivessel PCI for STEMI patients.
  • FFR has incremental value for assessing stenosis severity in STEMI patients with multivessel disease.
  • Further studies of vulnerable plaque are needed to obtain a complete risk assessment in STEMI patients.

Original Studies

Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial

Tuncay Yetgin MD,  Matthijs van Kranenburg MD,  Tim ten Cate MD, PhD,  Dirk J. Duncker MD, PhD,  Menko-Jan de Boer MD, PhD,  Roberto Diletti MD,  Robert-Jan M. van Geuns MD, PhD,  Felix Zijlstra MD, PhD,  Olivier C. Manintveld MD, PhD, 
  • Pages: 508-514
  • First Published: 10 September 2015

Editorial Comment

Ischemic Postconditioning: Not Giving Up Yet

Jorge A. Belardi MD, FACC, FSCAI,  Mariano Albertal MD, PhD, FACC, 
  • Pages: 514-515
  • First Published: 19 October 2016

Original Studies

The influence of advancing age on implantation of drug-eluting stents

Wenjie Tian MD,  Michael Mahmoudi MD, PhD,  Thibault Lhermusier MD,  Sarkis Kiramijyan MD,  Fang Chen PhD,  Rebecca Torguson MPH,  William O. Suddath MD,  Lowell F. Satler MD,  Augusto D. Pichard MD,  Ron Waksman MD, 
  • Pages: 516-521
  • First Published: 25 November 2015

Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study

Sandeep Basavarajaiah MD, MRCP,  Toru Naganuma MD,  Azeem Latib MD,  Alessandro Sticchi MD,  Giuseppe Ciconte MD,  Vasilis Panoulas MD,  Alaide Chieffo MD,  Matteo Montorfano MD,  Mauro Carlino MD,  Antonio Colombo MD, 
  • Pages: 522-528
  • First Published: 30 December 2015

Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study

Harald Rittger MD,  Jochen Wöhrle MD,  Johannes Brachmann MD,  Wolfgang Hohenforst-Schmidt MD,  Christian Schlundt MD,  Sandra Lonke MD,  Moritz von Cranach MD,  Sinisa Markovic MD,  Stephan Achenbach MD,  Matthias Waliszewski MD, 
  • Pages: 529-534
  • First Published: 19 February 2016
Open Access

“Real-World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States

Cynthia Larmore MSN,  Mark B. Effron MD,  Cliff Molife PhD,  Mitch DeKoven MHSA,  Yajun Zhu,  Jingsong Lu MS,  Swapna Karkare MS,  Hsiao D. Lieu MD,  Won Chan Lee PhD,  George W. Vetrovec MD, 
  • Pages: 535-544
  • First Published: 18 November 2015

Editorial Comment

ACS Treatment Continues to Improve: But Price Matters

Richard R. Heuser MD, FACC, FACP, FESC, FSCAI, 
  • Pages: 544-545
  • First Published: 19 October 2016

Original Studies

Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience

Christos Eftychiou MD, PhD,  David S. Barmby MBChB, MD,  Simon J. Wilson MD,  Salahaddin Ubaid MBChB,  Andrew J. Markwick MBChB,  Loukia Makri MSC,  Jonathan M. Blaxill MD,  James C. Spratt BSC, MD,  Mark Gunning MBChB, MD,  John P. Greenwood MBChB, PhD, 
  • Pages: 546-553
  • First Published: 03 June 2016

Editorial Comment

Fracking the Code to Complete Revascularization

Ravi S. Hira MD,  Larry S. Dean MD, 
  • Pages: 553-554
  • First Published: 19 October 2016

Editor's Choice

Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the FREAK Study)

Matteo Tebaldi MD,  Simone Biscaglia MD,  Massimo Fineschi MD,  Antonio Manari MD,  Mila Menozzi MD,  Gioel Gabrio Secco MD,  Emilio Di Lorenzo MD,  Fabrizio D'Ascenzo MD,  Fabio Fabbian MD,  Carlo Tumscitz MD,  Roberto Ferrari MD, PhD,  Gianluca Campo MD, 
  • Pages: 555-562
  • First Published: 31 December 2015

Editorial Comment

Not just a FREAK finding, but perhaps an important insight

Anene C. Ukaigwe MD,  Ian C. Gilchrist Sr MD, FSCAI, 
  • Pages: 562-564
  • First Published: 19 October 2016
Key Points

  • Chronic renal failure patients carry enhanced risk for coronary artery disease that may not be captured by simple FFR measurements
  • Microvascular resistance appears elevated in renal insufficiency and is a potential confounder that could result in a FFR higher than otherwise measured in a patient with normal microvascular system
  • The potential for microvascular resistance in the final interpretation of FFR values in chronic renal insufficient patients raises interesting questions for further outcomes based research

Case Report

First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis

Ehtisham Mahmud MD,  Arturo Dominguez MD,  John Bahadorani MD, 
  • Pages: 565-570
  • First Published: 18 May 2016

Pediatric and Congenital Heart Disease

Original Studies

Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series

Nikolaus A. Haas MD, PhD,  Dagmar B. Soetemann MD,  Ismail Ates MD, PhD,  Osman Baspinar MD,  Igor Ditkivskyy MD,  Christopher Duke MD,  Francois Godart MD, PhD,  Avraham Lorber MD, PhD,  Edmundo Oliveira MD,  Eustaquio Onorato MD,  Feyza Pac MD,  Worakan Promphan MD, PhD,  Frank-Thomas Riede MD,  Supaporn Roymanee MD, PhD,  Robert Sabiniewicz MD, PhD,  Suhair Omar Shebani MD,  Horst Sievert MD, PhD,  Do Tin MD,  Christoph M. Happel MD, PhD, 
  • Pages: 571-581
  • First Published: 31 March 2016

Initial Experience With the Pediatric Impella Device: A Feasibility Study in a Porcine Model

Melissa K. Webb MD,  Jian Wang MD,  Matthew S. Riegel DVM,  Kristine J. Guleserian MD,  Joseph M. Forbess MD,  Thomas M. Zellers MD,  V. Vivian Dimas MD, 
  • Pages: 582-589
  • First Published: 24 May 2016

Editorial Comment

Small Acute Mechanical Circulatory Support Pumps for Small People

Navin K. Kapur MD,  Michele Esposito MD, 
  • Pages: 590-591
  • First Published: 19 October 2016
Key Points

  • Webb and Dimas identify that use of vascular chimney grafts is better than direct cannulation for delivering the Impella 2.5 axial flow pump via the carotid artery in a swine model.
  • Given the growing demand for acute mechanical circulatory support (AMCS) pumps among pediatric patients, this report highlights vascular access techniques and equipment as a major unmet need for the pediatric population.
  • New vascular sheaths, grafts, and techniques are required for greater adoption of AMCS devices in pediatric patients.

Original Studies

Early catheterization after initiation of extracorporeal membrane oxygenation support in children is associated with improved survival

Boban P. Abraham MD,  Erikka Gilliam BA, MPH,  Dennis W. Kim MD, PhD,  Michael J. Wolf MD,  Robert N. Vincent MD,  Christopher J. Petit MD, 
  • Pages: 592-599
  • First Published: 01 April 2016

Case Report

Non-infectious thrombosis of the melody® valve: A tale of two cities

Andrew E. Schneider MD,  Jeffrey W. Delaney MD,  Allison K. Cabalka MD, 
  • Pages: 600-604
  • First Published: 20 July 2016

Peripheral Vascular Disease

Original Studies

Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011)

Shilpkumar Arora MD,  Sidakpal S. Panaich MD,  Nilay Patel MD,  Nileshkumar J. Patel MD,  Sopan Lahewala MD,  Badal Thakkar MD,  Chirag Savani MD,  Sunny Jhamnani MD,  Vikas Singh MD,  Nish Patel MD,  Samir Patel MD,  Rajesh Sonani MD,  Achint Patel MD,  Byomesh Tripathi MD,  Abhishek Deshmukh MD,  Ankit Chothani MD,  Jay Patel MD,  Parth Bhatt MD,  Tamam Mohamad MD,  Michael S. Remetz MD,  Jeptha P. Curtis MD,  Ramak R. Attaran MD,  Carlos I. Mena MD,  Theodore Schreiber MD,  Cindy Grines MD,  Michael Cleman MD,  John K. Forrest MD,  Apurva O. Badheka MD FACP CCDS RPVI, 
  • Pages: 605-616
  • First Published: 23 February 2016

Editorial Comment

Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011)

Angela Echeverria PharmD, MD,  Zvonimir Krajcer MD, 
  • Pages: 616-617
  • First Published: 19 October 2016

Valvular and Structural Heart Diseases

Original Studies

A New Specific Device in Transcatheter Prosthetic Paravalvular Leak Closure: A Prospective Two-Center Trial

Aydin Yildirim MD,  Omer Goktekin MD,  Sevket Gorgulu MD,  Tugrul Norgaz MD,  Emre Akkaya MD,  Unal Aydin MD,  Hale Unal Aksu MD,  Ihsan Bakir MD, 
  • Pages: 618-624
  • First Published: 23 February 2016

Editorial Comment

Paravalvular Leaks: One Size (or Shape) Doesn't Always Fit All?

Andre Paixao MD, FSCAI, FACC,  Mehmet Cilingiroglu MD, FSCAI, FACC, FESC, 
  • Pages: 624-625
  • First Published: 19 October 2016

Original Studies

Two-Year Follow Up After Surgical Versus Percutaneous Paravalvular Leak Closure: A Non-Randomized Analysis

Rocío Angulo-Llanos MD,  Fernando Sarnago-Cebada MD,  Allan R. Rivera MD,  Jaime Elízaga Corrales Md, PhD,  Gregorio Cuerpo MD,  Jorge Solis MD,  Enrique Gutierrez-Ibañes MD,  Ricardo Sanz-Ruiz MD,  ME Vázquez Álvarez MD,  Francisco Fernandez-Avilés MD, PhD, 
  • Pages: 626-634
  • First Published: 04 March 2016

Editorial Comment

Surgical vs Percutaneous Approaches to Paravalvular Leak: Is Closure Too Little Too Late, or Just Not Soon Enough: Editorial Comment on CCI-15-1144.R1: Two-year Follow-up After Surgical Versus Percutaneous Paravalvular Leak Closure: A Non Randomized Analysis.

Ted Feldman MD, FESC, FACC, MSCAI,  Fabian Nietlispach MD, 
  • Pages: 634-635
  • First Published: 19 October 2016
Key Points

  • Percutaneous paravalvular leak (PVL) closure has lower procedure mortality than surgical closure in a non-randomized comparison
  • Both percutaneous and surgical PVL closure have high long-term mortality with nearly half of patients dead after 2.5 years
  • Multivariate analysis showed age, worse NYHA class, and renal failure were associated with worse prognosis
  • Earlier detection and treatment of PVL should be considered to improve late results

Original Studies

Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve

Birgid Gonska MD,  Julia Seeger MD,  Christoph Rodewald MD,  Dominik Scharnbeck MD,  Wolfgang Rottbauer MD,  Jochen Wöhrle MD, 
  • Pages: 636-643
  • First Published: 03 May 2016

Incidence and Clinical Impact of Stroke Complicating Transcatheter Aortic Valve Implantation: Results From the German TAVI Registry

Nicolas Werner MD,  Uwe Zeymer MD,  Steffen Schneider PhD,  Timm Bauer MD,  Ulrich Gerckens MD,  Axel Linke MD,  Christian Hamm MD,  Horst Sievert MD,  Holger Eggebrecht MD,  Ralf Zahn MD,  on behalf of the German Transcatheter Aortic Valve Interventions-Registry Investigators , 
  • Pages: 644-653
  • First Published: 03 June 2016

Editorial Comment

Stroke Prevention: Let's Prepare for Generation X TAVR

Laura J. Davidson MD,  Charles J. Davidson MD, FSCAI, 
  • Pages: 653-655
  • First Published: 19 October 2016

Original Studies

Percutaneous left atrial appendage occlusion: Effect of device positioning on outcome

Mathias Wolfrum MD,  Adrian Attinger-Toller MD,  Samera Shakir MD,  Steffen Gloekler MD,  Burkhardt Seifert PhD,  Aris Moschovitis MD,  Ahmed Khattab MD,  Francesco Maisano MD,  Bernhard Meier MD,  Fabian Nietlispach MD PhD, 
  • Pages: 656-664
  • First Published: 28 July 2016

Case Report

Transcatheter aortic valve replacement for native aortic valve regurgitation as a bridge to liver transplantation

Alduz S. Cabasa MD,  Mackram F. Eleid MD,  Rakesh M. Suri MD, DPHIL, 
  • Pages: 665-670
  • First Published: 01 October 2015

E-Only: Coronary Artery Disease

Original Studies

Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease

Carlos E. Sanchez MD, FACC,  Anthony Dota MD,  Vinay Badhwar MD, FACC,  Dustin Kliner MD,  A.J. Conrad Smith MD, FACC,  Danny Chu MD,  Catalin Toma MD, FACC,  Lawrence Wei MD,  Oscar C. Marroquin MD, FACC,  John Schindler MD, FACC,  Joon S. Lee MD, FACC,  Suresh R. Mulukutla MD, FACC, 
  • Pages: E103-E112
  • First Published: 03 November 2015

E-Only: Pediatric and Congenital Heart Disease

Case Report

Esophageal perforation caused by an AMPLATZERTM vascular plug 4 occlusion device

Gesa Wiegand MD,  Christian Schlensak MD,  Michael Hofbeck MD, 
  • Pages: E113-E116
  • First Published: 03 June 2016

E-Only: Non-Invasive Angiography

Original Studies

Dual-Source Computed Tomography for Chronic Total Occlusion of Coronary Arteries

Sandeep Singh MD, DM,  Navreet Singh MD, DM,  Gurpreet S. Gulati MD,  Sivasubramanian Ramakrishnan MD, DM,  Guresh Kumar MPHIL, PhD,  Sanjiv Sharma MD,  Vinay K. Bahl MD, DM, 
  • Pages: E117-E125
  • First Published: 16 April 2014

E-Only: Coronary Artery Disease

Original Studies

Prevalence of aspirin resistance in Asian-Indian patients with stable coronary artery disease

D.S. Chadha MD,  Budha Sumana MS,  Ganesan Karthikeyan MD,  V. Jayaprasad MD,  Shet S. Arun MD, 
  • Pages: E126-E131
  • First Published: 31 January 2014